Abstract:Background: Brain-derived neurotrophic factor (BDNF) has been implicated in the pathophysiology of heroin dependence. BDNF expression is dramatically changed during drug withdrawal, and is associated with drug withdrawal syndrome. This study aimed to explore (1) alterations of BDNF serum levels in heroin-dependent patients after long term abstinence; and (2) the association between BDNF serum levels and protracted withdrawal syndrome.Method: Fifty-three male heroin-dependent patients and fifty-two gender-matched healthy controls were enrolled in this study. We measured BDNF serum levels at baseline and 26 weeks after heroin abstinence. Moreover, protracted withdrawal symptoms, depression and anxiety symptoms were measured by Protracted Withdrawal Symptoms of Heroin-dependent patients (PWSHA), Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS), respectively.Result: We found that baseline BDNF serum levels were significantly lower in heroin-dependent patients compared to controls (p < 0.01). There was also a significantly difference in BDNF serum levels among heroin-dependent patients at baseline and 26-week follow-up (p < 0.01). The BDNF serum levels were not associated with age, BMI, years of education, age of initial use, or duration of use. Of the clinical symptoms measured, the change in BDNF serum levels from baseline to 26-week follow-up was negatively associated with the change in PWSHA scores (r = 0.44, p < 0.01, see Table 2 and Figure 2 for details).Conclusion: The results show that the BDNF serum levels in heroin-dependent patients are lower than those of healthy controls at baseline and increased after 26 weeks of abstinence, although the BDNF serum levels are still lower than those of the healthy controls. A negative correlation between the change in BDNF serum levels and protracted withdrawal symptoms was found but needs to be confirmed in further study. The results revealed that BDNF serum level is worth paying attention to in order to further investigate the possibility of it being a biomarker of treatment outcome for opiate dependence. (C) 2015 Elsevier Inc. All rights reserved.

Plasma Metabolites Changes in Male Heroin Addicts During Acute and Protracted Withdrawal.

The Changes in Thyroid Function of Heroin Addicts after Detoxification

The Sexual Function of Male Heroin Addicts

Integration of Molecular Inflammatory Interactome Analyses Reveals Dynamics of Circulating Cytokines and Extracellular Vesicle Long Non-Coding RNAs and Mrnas in Heroin Addicts During Acute and Protracted Withdrawal

A Study of Symptom Checklist 90 (SCL-90) of Heroin Addicts after Detoxification

Metabolic Phenotype of Rats Exposed to Heroin and Potential Markers of Heroin Abuse

Brain Function of Heroin Addicts after Withdrawal.

Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.

Proteomic analysis of plasma from heroin abuser sunder immobilized Ph gradients 4 -7

Immune Function Alterations During 12 Weeks of Abstinence in Heroin Users.

Transcriptomics and Metabolomics Together Reveal the Underlying Mechanism of Heroin Hepatotoxicity

Blood Plasma Proteomic Changes in a Range of Ph4～7 among Heroin Abuser

Analysis of serum metabonomics in patients with methamphetamine induced withdrawal disorder in nervous system

Determination of Metabolic Phenotype and Potential Biomarkers in the Liver of Heroin Addicted Mice with Hepatotoxicity.

Dynamics and Correlations in Multiplex Immune Profiling Reveal Persistent Immune Inflammation in Male Drug Users after Withdrawal

Circadian alteration in neurobiology during 30 days of abstinence in heroin users.

Serum Proteomic Analysis Reveals High Frequency of Haptoglobin Deficiency and Elevated Thyroxine Level in Heroin Addicts.

Changes in Brain Gray Matter in Abstinent Heroin Addicts.

Dynamics of Neurotransmitter and Extracellular Vesicle-Derived Microrna Landscapes During Heroin and Methamphetamine Withdrawal

Reversible Brain White Matter Microstructure Changes in Heroin Addicts: A Longitudinal Study

Brain-derived Neurotrophic Factor Serum Levels in Heroin-Dependent Patients after 26weeks of Withdrawal.